TENX compared with OCGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TENXTenax Therapeutics, Inc.

Mkt capRevenueRevenue

OCGNOcugen, Inc.

Mkt capRevenueRevenue

Compare

TENXTenax Therapeutics, Inc.

OCGNOcugen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TENX 1

—Orionunlistedsupplier

Shared 0

No shared counterparties.

Only OCGN 11

—CanSino Biologicsunlistedsupplier

—CanSinoBIOunlistedsupplier

—National Institute of Allergy and Infectious Diseases (NIAID)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Washington University in St. Louisunlistedsupplier

7 more · OCGN chain ›

TENXTenax Therapeutics, Inc.

1.70▲+3.99%· post 1.70

Mkt cap$77.0MRevenue—Revenue—

OCGNOcugen, Inc.

0.93▲+13.30%· post 0.93

ClosedNov 6 '26

Mkt cap$313.9MRevenue$2MQ3 FY26Revenue$4MFY24

Compare

ClosedNov 6 '26

TENXTenax Therapeutics, Inc.

OCGNOcugen, Inc.

1.70▲+3.99%post 1.70

Price

0.93▲+13.30%post 0.93

$77.0M

Mkt cap

$313.9M

—

Revenue

$2MQ3 FY26

—

Revenue

$4MFY24

TENX1.70▲+3.99%vsOCGN0.93▲+13.30%ClosedNov 6 '26